Referral to an oral Disintegration Tablet comprising: (i) fine Granules that show a controlled release of a pharmaceutically Active Ingredient, which comprises Fine Granules containing a pharmaceutically Active Ingredient and a coating layer comprising a COPOLYMER Methacrylic acid \/ Methyl acrylate \/ Methyl methacrylateThe Fine Granules are coated with more than 80% and not more than 300% by weight of the Copolymer and (ii) fine Granules that show a controlled release of a pharmaceutically Active Ingredient,That includes the pharmaceutically Active Ingredient and a coating layer comprising: a) a Copolymer of Ethyl acrylate \/ Methyl methacrylate and (b) one or several types of Polymers such as hypromellose Phthalate, hydroxypropyl methylcellulose acetate succinate, among others. The pharmaceutically Active Ingredient is lansoprazole, a form of optically active or its Salts.These Coating layers comprise a plasticizer. In addition, The Tablet comprises an Additive such as soluble Sugar alcoholREFERIDO A UN COMPRIMIDO DE DESINTEGRACION ORAL QUE COMPRENDE: i) GRANULOS FINOS QUE MUESTRAN UNA LIBERACION CONTROLADA DE UN INGREDIENTE FARMACEUTICAMENTE ACTIVO, QUE COMPRENDE GRANULOS FINOS QUE CONTIENEN UN INGREDIENTE FARMACEUTICAMENTE ACTIVO Y UNA CAPA DE RECUBRIMIENTO QUE COMPRENDE COPOLIMERO DE ACIDO METACRILICO/ACRILATO DE METILO/METACRILATO DE METILO, LOS GRANULOS FINOS ESTAN RECUBIERTOS CON MAS DEL 80% Y NO MAS DEL 300% EN PESO DEL COPOLIMERO Y ii) GRANULOS FINOS QUE MUESTRAN UNA LIBERACION CONTROLADA DE UN INGREDIENTE FARMACEUTICAMENTE ACTIVO, QUE COMPRENDE EL INGREDIENTE FARMACEUTICAMENTE ACTIVO Y UNA CAPA DE RECUBRIMIENTO QUE COMPRENDE: a) UN COPOLIMERO DE ACRILATO DE ETILO/METACRILATO DE METILO Y b) UNO O VARIOS TIPOS DE POLIMEROS TAL COMO FTALATO DE HIPROMELOSA, ACETATO SUCCINATO DE HIDROXIPROPILMETILCELULOSA, ENTRE OTROS. EL INGREDIENTE FARMACEUTICAMENTE ACTIVO ES LANZOPRAZOL, UNA DE SUS FORMAS OPTICAMENTE ACTIVOS O SUS SALES. DICHAS CAPAS DE RECUBRIMIENTO COMPR
